Filip, S <br/><br/>
Myeloid differentiation and maturation of SCF+IL-3+IL-11 expanded AC133+/CD34+ cells selected from high-risk breast cancer patients.  [electronic resource] 

 -  Neoplasma  2000 
 - 73-80 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0028-2685 
<br/><br/><label>Subjects--Topical Terms: </label><br/>AC133 Antigen<br/>Adult<br/>Antigens, CD<br/>Antigens, CD34--biosynthesis<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Breast Neoplasms--blood<br/>Cyclophosphamide--adverse effects<br/>Etoposide--administration & dosage<br/>Female<br/>Glycoproteins--biosynthesis<br/>Granulocyte Colony-Stimulating Factor--administration & dosage<br/>Hematopoietic Cell Growth Factors--pharmacology<br/>Hematopoietic Stem Cell Mobilization<br/>Hematopoietic Stem Cells--cytology<br/>Humans<br/>Interleukin-11--pharmacology<br/>Interleukin-3--pharmacology<br/>Leukapheresis<br/>Middle Aged<br/>Peptides--blood<br/>Recombinant Proteins--pharmacology<br/>Stem Cell Factor--pharmacology